Zivo Bioscience amends 8-K to correct date typo in director stock award from 2023

Zivo Bioscience, Inc.

Corrects date in Item 1.01 from erroneous date to December 29, 2023.
Board approved 261,619 shares to three non-employee directors for unpaid 2023 fees of $172,670.
Shares issued at $1.20 per share (Dec 29, 2023 close), grossed up for taxes at 45%.
Directors Cornell (95k), Masterson (85k), Maggiore (82k) accepted grants on June 5, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.